首页 > 最新文献

Journal of Ayurveda and Integrative Medicine最新文献

英文 中文
Synthesis and characterization of Sajjikshara derived from two distinct sources: herbal and mineral 从两种不同的来源:草药和矿物质中提取的沙吉沙拉的合成和表征
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 DOI: 10.1016/j.jaim.2025.101264
Piyush Krantikumar Gandhi , Rajesh Kundlikrao Ingole , Ganesh Nigade

Background

Sajjikshara is derived from both plant and mineral sources. It is important to note that the API does not specify standards for Sajjikshara obtained from herbal and Mineral sources. Therefore, a comparative physicochemical analysis is essential to determine its composition.

Objectives

This study was designed to compare Sajjikshara prepared from two distinct sources: herbal-mineral, in terms of pharmaceutics and analytical parameters.

Material and methods

Sajjikshara was prepared using the ash of Duaralabha Panchang (the whole plant of Fagonia cretica Linn.) and Sajjimitti (a special type of soil) according to textual references from Rasa Tarangini and Rasajalanidhi. Both herbal and mineral Sajjikshara (Sajjikshara-H and M, respectively) were analysed using various physicochemical parameters, phytochemical parameters, and concentrations of sodium (Na), potassium (K), carbonate, hydroxide, sulfate, and nitrate groups, as well as microbial load, aflatoxin concentration, and heavy metals (arsenic, mercury, and lead). X-ray diffraction (XRD) analysis was conducted to identify the crystals, and Fourier transform Infra-Red (FTIR) spectroscopy was used to determine the functional groups present in both types of Sajjikshara.

Results

The pH of both Sajjikshara types is approximately the same, exhibiting an alkaline nature. Sajjikshara-M has a higher percentage of ash value, acid-insoluble ash, and concentrations of Na, K, and carbonate groups. The absence of heavy metals, microbial load, and aflatoxins in both Sajjikshara indicates careful preparation. FTIR and XRD analyses of both Sajjikshara types reveal the presence of carbonate crystals.

Conclusion

Sajjikshara derived from minerals contains a higher percentage of sodium, carbonates, and is cost-effective.
sajjikshara来源于植物和矿物。值得注意的是,API没有规定从草药和矿物来源获得的Sajjikshara的标准。因此,比较物理化学分析是确定其组成的必要条件。目的比较两种不同药材来源的沙吉散的药理成分和分析参数。材料和方法根据《Rasa Tarangini》和《Rasajalanidhi》的文献资料,用Duaralabha Panchang (Fagonia cretica Linn.)的全株灰和Sajjimitti(一种特殊土壤)的灰制备了sajjikshara。利用各种理化参数、植物化学参数、钠(Na)、钾(K)、碳酸盐、氢氧化物、硫酸盐和硝酸盐的浓度以及微生物负荷、黄曲霉毒素浓度和重金属(砷、汞和铅)对草药和矿物Sajjikshara(分别为Sajjikshara- h和M)进行了分析。x射线衍射(XRD)分析鉴定了晶体,傅里叶变换红外光谱(FTIR)分析了两种类型的Sajjikshara中存在的官能团。结果两种类型的酸碱度基本相同,均呈碱性。Sajjikshara-M具有较高的灰分值、酸不溶性灰分百分比以及Na、K和碳酸盐基团的浓度。在这两种Sajjikshara中都没有重金属、微生物负荷和黄曲霉毒素,这表明制备是仔细的。两种Sajjikshara类型的FTIR和XRD分析显示碳酸盐晶体的存在。结论矿物油中钠、碳酸盐含量较高,具有较高的性价比。
{"title":"Synthesis and characterization of Sajjikshara derived from two distinct sources: herbal and mineral","authors":"Piyush Krantikumar Gandhi ,&nbsp;Rajesh Kundlikrao Ingole ,&nbsp;Ganesh Nigade","doi":"10.1016/j.jaim.2025.101264","DOIUrl":"10.1016/j.jaim.2025.101264","url":null,"abstract":"<div><h3>Background</h3><div><em>Sajjikshara</em> is derived from both plant and mineral sources. It is important to note that the API does not specify standards for <em>Sajjikshara</em> obtained from herbal and Mineral sources. Therefore, a comparative physicochemical analysis is essential to determine its composition.</div></div><div><h3>Objectives</h3><div>This study was designed to compare <em>Sajjikshara</em> prepared from two distinct sources: herbal-mineral, in terms of pharmaceutics and analytical parameters.</div></div><div><h3>Material and methods</h3><div><em>Sajjikshara</em> was prepared using the ash of <em>Duaralabha Panchang</em> (the whole plant of <em>Fagonia cretica</em> Linn.) and <em>Sajjimitti</em> (a special type of soil) according to textual references from Rasa Tarangini and Rasajalanidhi. Both herbal and mineral <em>Sajjikshara</em> (<em>Sajjikshara</em>-H and M, respectively) were analysed using various physicochemical parameters, phytochemical parameters, and concentrations of sodium (Na), potassium (K), carbonate, hydroxide, sulfate, and nitrate groups, as well as microbial load, aflatoxin concentration, and heavy metals (arsenic, mercury, and lead). X-ray diffraction (XRD) analysis was conducted to identify the crystals, and Fourier transform Infra-Red (FTIR) spectroscopy was used to determine the functional groups present in both types of <em>Sajjikshara</em>.</div></div><div><h3>Results</h3><div>The pH of both <em>Sajjikshara</em> types is approximately the same, exhibiting an alkaline nature. <em>Sajjikshara</em>-M has a higher percentage of ash value, acid-insoluble ash, and concentrations of Na, K, and carbonate groups. The absence of heavy metals, microbial load, and aflatoxins in both <em>Sajjikshara</em> indicates careful preparation. FTIR and XRD analyses of both <em>Sajjikshara</em> types reveal the presence of carbonate crystals.</div></div><div><h3>Conclusion</h3><div><em>Sajjikshara</em> derived from minerals contains a higher percentage of sodium, carbonates, and is cost-effective.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101264"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145463171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Yoga and naturopathic intervention on cardiac autonomic functions in chronic kidney disease with coronary artery disease – A Case Series 瑜伽和自然疗法干预对慢性肾病合并冠状动脉疾病患者心脏自主神经功能的影响
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 DOI: 10.1016/j.jaim.2025.101261
Deepa Yoganathan , Vimal Vadivel , Vaishali Narayanan , Maheshkumar Kuppusamy , Meenakshi Venkatesan
Chronic kidney disease (CKD) and coronary artery disease (CAD) are significant global health challenges with high mortality rates. Conventional treatments often yield limited satisfaction, necessitating exploration of integrative therapeutic approaches. Four patients (3 males, 1 female; ages 39–56) with confirmed CKD (eGFR <15 ml/min) and CAD were enrolled. Patients presented with symptoms including breathing difficulties, chest heaviness, and reduced cardiac function, and were unsatisfied with previous conventional treatments. Patients underwent a 15-day intense program combining yoga, acupuncture, hydrotherapy, manipulative therapy, and specialised naturopathic diet. Daily yoga sessions lasted 60–75 minutes and included specific asanas, breathing techniques and relaxation practices. Heart rate variability (HRV) analysis revealed significant improvements across multiple autonomic function markers, observed across all patients. Mean RR intervals increased, with case 3 rising from 582 ms to 675 ms. RMSSD improved from 22.5 ms to 46.9 ms in case 1, indicating enhanced parasympathetic activity. The Stress Index decreased across all cases, most notably in case 3 from 96.4 to 44.8. The LF/HF ratio approached more balanced levels, with case 3 moving from 2.633 to 0.995, suggesting improved autonomic regulation. The integrated yoga and naturopathic intervention demonstrated potential in improving cardiac autonomic functions in CKD and CAD patients. Results suggest these complementary approaches may offer a promising adjunct to conventional medical management by modulating autonomic nervous system activity.
慢性肾脏疾病(CKD)和冠状动脉疾病(CAD)是具有高死亡率的重大全球健康挑战。常规治疗往往产生有限的满意度,有必要探索综合治疗方法。入选4例确诊CKD (eGFR <15 ml/min)和CAD的患者(3男1女,年龄39-56岁)。患者出现呼吸困难、胸重、心功能下降等症状,既往常规治疗不满意。患者接受了为期15天的高强度项目,包括瑜伽、针灸、水疗、手法疗法和专门的自然疗法饮食。每天的瑜伽课程持续60-75分钟,包括特定的体式、呼吸技巧和放松练习。心率变异性(HRV)分析显示,在所有患者中观察到的多种自主神经功能指标均有显著改善。平均RR间隔增加,病例3从582 ms增加到675 ms。病例1的RMSSD从22.5 ms提高到46.9 ms,表明副交感神经活动增强。所有病例的压力指数均有所下降,其中病例3的压力指数从96.4降至44.8。LF/HF比值接近更平衡的水平,病例3从2.633移动到0.995,表明自主调节得到改善。综合瑜伽和自然疗法干预显示出改善CKD和CAD患者心脏自主神经功能的潜力。结果表明,这些补充方法可能通过调节自主神经系统活动,为传统医学管理提供了一个有希望的辅助方法。
{"title":"Effects of Yoga and naturopathic intervention on cardiac autonomic functions in chronic kidney disease with coronary artery disease – A Case Series","authors":"Deepa Yoganathan ,&nbsp;Vimal Vadivel ,&nbsp;Vaishali Narayanan ,&nbsp;Maheshkumar Kuppusamy ,&nbsp;Meenakshi Venkatesan","doi":"10.1016/j.jaim.2025.101261","DOIUrl":"10.1016/j.jaim.2025.101261","url":null,"abstract":"<div><div>Chronic kidney disease (CKD) and coronary artery disease (CAD) are significant global health challenges with high mortality rates. Conventional treatments often yield limited satisfaction, necessitating exploration of integrative therapeutic approaches. Four patients (3 males, 1 female; ages 39–56) with confirmed CKD (eGFR &lt;15 ml/min) and CAD were enrolled. Patients presented with symptoms including breathing difficulties, chest heaviness, and reduced cardiac function, and were unsatisfied with previous conventional treatments. Patients underwent a 15-day intense program combining yoga, acupuncture, hydrotherapy, manipulative therapy, and specialised naturopathic diet. Daily yoga sessions lasted 60–75 minutes and included specific <em>asanas</em>, breathing techniques and relaxation practices. Heart rate variability (HRV) analysis revealed significant improvements across multiple autonomic function markers, observed across all patients. Mean RR intervals increased, with case 3 rising from 582 ms to 675 ms. RMSSD improved from 22.5 ms to 46.9 ms in case 1, indicating enhanced parasympathetic activity. The Stress Index decreased across all cases, most notably in case 3 from 96.4 to 44.8. The LF/HF ratio approached more balanced levels, with case 3 moving from 2.633 to 0.995, suggesting improved autonomic regulation. The integrated yoga and naturopathic intervention demonstrated potential in improving cardiac autonomic functions in CKD and CAD patients. Results suggest these complementary approaches may offer a promising adjunct to conventional medical management by modulating autonomic nervous system activity.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101261"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145463172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurvedic management of psoriatic arthritis with Dactylitis - A Case Report 阿育吠陀治疗银屑病关节炎伴指炎1例
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 DOI: 10.1016/j.jaim.2025.101200
Sinimol Thekkekkootumughath Peethambaran , Sree Deepthi Girija Nalinakshan
This case report is the description of dactylitis associated with Psoriatic arthritis (PsA) of a thirty-eight years old male, government employee. He presented with complaints of pain, swelling, stiffness and restriction of movements in fingers of upper limb, especially distal interphalangeal joints (IJP) for 1 month. Skin manifestations like silvery flaky scales, itching over the scalp region and mild pinkish discoloration on mid dorsum of right foot were also present. Diagnosis was made with the aid of CASPAR criteria, history taking and clinical examination. Only temporary relief was obtained from non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs) he had taken for 2 weeks as suggested by conventional treatment. In Ayurvedic parlance, PsA resembles conditions like Gambheera Vatrakta, due to involvement of skin and deeper tissues like bones and joints and dactylitis may be considered as Anguli sopha. Internal medications with properties alleviating three doshas (tridoshahara), skin diseases (kushtahara), vitiated rakta dhatu (raktahara), which detoxifies blood (raktaprasadana), anodyne (soolahara), anti-inflammatory (shothahara), rejuvenating (Rasayana) were used. The assessment was done before and after the treatment by using the Psoriasis Area and Severity Index (PASI) score and European Alliance of Associations for Rheumatology's ‘The Psoriatic Arthritis Impact of Disease 12 (EULAR PsAID 12)’ questionnaire score. It was observed that symptoms were almost completely resolved with Ayurvedic management and changes in biochemical parameters were also noted. Prescribed Ayurvedic medications was found to be a good alternative therapy in managing dactylitis associated with PsA.
本病例报告描述了一名38岁男性政府雇员的指炎与银屑病关节炎(PsA)相关。患者主诉上肢手指疼痛、肿胀、僵硬和活动受限,特别是远端指间关节(IJP) 1个月。皮肤表现为银色片状鳞片,头皮瘙痒,右脚中背轻度粉红色变色。结合CASPAR标准、病史和临床检查进行诊断。非甾体类抗炎药(NSAIDs)和改善疾病的抗风湿药(DMARDs)按照常规治疗建议服用了2周,只有暂时的缓解。在阿育吠陀的说法中,PsA类似于Gambheera Vatrakta,由于涉及皮肤和更深的组织,如骨骼和关节,趾炎可能被认为是Anguli sopha。使用了能够缓解三散(tridoshahara)、皮肤病(kushtahara)、能够解毒血液(raktaprasadana)、止痛(soolahara)、抗炎(shothahara)、恢复活力(Rasayana)的内部药物。通过银屑病面积和严重程度指数(PASI)评分和欧洲风湿病协会联盟的“银屑病关节炎对疾病的影响12 (EULAR PsAID 12)”问卷评分,在治疗前后进行评估。观察到,阿育吠陀治疗几乎完全解决了症状,还注意到生化参数的变化。处方阿育吠陀药物被发现是一个很好的替代疗法,在管理指炎与PsA相关。
{"title":"Ayurvedic management of psoriatic arthritis with Dactylitis - A Case Report","authors":"Sinimol Thekkekkootumughath Peethambaran ,&nbsp;Sree Deepthi Girija Nalinakshan","doi":"10.1016/j.jaim.2025.101200","DOIUrl":"10.1016/j.jaim.2025.101200","url":null,"abstract":"<div><div>This case report is the description of dactylitis associated with Psoriatic arthritis (PsA) of a thirty-eight years old male, government employee. He presented with complaints of pain, swelling, stiffness and restriction of movements in fingers of upper limb, especially distal interphalangeal joints (IJP) for 1 month. Skin manifestations like silvery flaky scales, itching over the scalp region and mild pinkish discoloration on mid dorsum of right foot were also present. Diagnosis was made with the aid of CASPAR criteria, history taking and clinical examination. Only temporary relief was obtained from non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs) he had taken for 2 weeks as suggested by conventional treatment. In Ayurvedic parlance, PsA resembles conditions like <em>Gambheera Vatrakta</em>, due to involvement of skin and deeper tissues like bones and joints and dactylitis may be considered as <em>Anguli sopha</em>. Internal medications with properties alleviating three doshas <em>(tridoshahara</em>)<em>,</em> skin diseases <em>(kushtahara),</em> vitiated <em>rakta dhatu (raktahara)</em>, which detoxifies blood <em>(raktaprasadana),</em> anodyne <em>(soolahara),</em> anti-inflammatory <em>(shothahara),</em> rejuvenating <em>(Rasayana)</em> were used. The assessment was done before and after the treatment by using the Psoriasis Area and Severity Index (PASI) score and European Alliance of Associations for Rheumatology's ‘The Psoriatic Arthritis Impact of Disease 12 (EULAR PsAID 12)’ questionnaire score. It was observed that symptoms were almost completely resolved with Ayurvedic management and changes in biochemical parameters were also noted. Prescribed Ayurvedic medications was found to be a good alternative therapy in managing dactylitis associated with PsA.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101200"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145463173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-inflammatory effects of Glycyrrhiza glabra homeopathic formulations in a rat model of lipopolysaccharide-induced inflammation 甘草顺势疗法制剂对脂多糖诱导炎症大鼠模型的抗炎作用
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 DOI: 10.1016/j.jaim.2025.101267
Bharti Gawai, Amol A. Tagalpallewar, Anil T. Pawar, Akshay M. Baheti

Background

Inflammation plays a crucial role in the pathogenesis of various chronic diseases. Alternative therapies, such as homeopathy, have gained attention for their potential in managing inflammatory conditions. Glycyrrhiza glabra, commonly known as licorice, is well-documented for its anti-inflammatory properties in herbal medicine. However, its efficacy in homeopathic formulations remains largely unexplored.

Objective

This study aimed to evaluate the anti-inflammatory potential of different homeopathic potencies of Glycyrrhiza glabra against lipopolysaccharide (LPS)-induced inflammation in rats.

Methods

Male Wistar rats were divided into seven groups: normal control, LPS-induced inflammation control, dexamethasone-treated, Glycyrrhiza glabra homeopathic mother tincture (GHMT)-treated, and groups treated with Glycyrrhiza glabra homeopathic potency (G6CH, G30CH, G200CH). Anti-inflammatory effects of GHMT, G6CH, G30CH, and G200CH were evaluated against LPS-induced inflammation by measuring paw volume, serum pro-inflammatory cytokine levels [tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6)], levels of oxidative stress biomarkers (superoxide dismutase, glutathione, and catalase) in paw tissues, and histopathological changes in inflamed paw tissues.

Results

The results demonstrated a significant reduction in paw volume in GHMT and G200CH-treated groups (p<0.0001) as compared to the inflammation control group. Additionally, the levels of serum TNF-α and IL-6 were significantly lowered (p<0.0001), and oxidative stress biomarkers showed significant improvement (p<0.0001) in GHMT and G200CH-treated groups. Histopathological examination further confirmed the reversal of inflammation-induced tissue changes by G. glabra homeopathic formulations, indicating its anti-inflammatory activity.

Conclusion

These findings provide scientific evidence supporting the anti-inflammatory potential of homeopathic formulations of Glycyrrhiza glabra, particularly GHMT and G200CH. The study suggests that these homeopathic potencies could serve as promising alternative anti-inflammatory agents, warranting further research to elucidate the underlying molecular mechanisms.
背景:炎症在各种慢性疾病的发病机制中起着至关重要的作用。替代疗法,如顺势疗法,因其在控制炎症条件方面的潜力而受到关注。甘草,俗称甘草,在草药中有很好的抗炎特性。然而,它在顺势疗法配方中的功效仍未得到很大程度的探索。目的探讨不同顺势疗法甘草对脂多糖(LPS)诱导的大鼠炎症的抗炎作用。方法将Wistar雄性大鼠分为正常对照组、脂多糖诱导炎症对照组、地塞米松组、甘草顺势疗法母酊组(GHMT)组和甘草顺势疗法药效组(G6CH、G30CH、G200CH)。通过测量足部体积、血清促炎细胞因子[肿瘤坏死因子-α (TNF-α)和白细胞介素-6 (IL-6)]水平、足部组织氧化应激生物标志物(超氧化物歧化酶、谷胱甘肽和过氧化氢酶)水平以及足部炎症组织的组织病理学变化,评估GHMT、G6CH、G30CH和G200CH对lps诱导炎症的抗炎作用。结果结果显示,与炎症对照组相比,GHMT和g200ch处理组的足部体积显著减少(p<0.0001)。此外,GHMT和g200ch处理组血清TNF-α和IL-6水平显著降低(p<0.0001),氧化应激生物标志物显著改善(p<0.0001)。组织病理学检查进一步证实了光天葵顺势疗法配方对炎症诱导的组织改变的逆转作用,表明其具有抗炎活性。结论顺势疗法甘草制剂具有抗炎作用,特别是GHMT和G200CH。该研究表明,这些顺势疗法的效力可以作为有希望的替代抗炎剂,需要进一步研究以阐明潜在的分子机制。
{"title":"Anti-inflammatory effects of Glycyrrhiza glabra homeopathic formulations in a rat model of lipopolysaccharide-induced inflammation","authors":"Bharti Gawai,&nbsp;Amol A. Tagalpallewar,&nbsp;Anil T. Pawar,&nbsp;Akshay M. Baheti","doi":"10.1016/j.jaim.2025.101267","DOIUrl":"10.1016/j.jaim.2025.101267","url":null,"abstract":"<div><h3>Background</h3><div>Inflammation plays a crucial role in the pathogenesis of various chronic diseases. Alternative therapies, such as homeopathy, have gained attention for their potential in managing inflammatory conditions. <em>Glycyrrhiza glabra</em>, commonly known as licorice, is well-documented for its anti-inflammatory properties in herbal medicine. However, its efficacy in homeopathic formulations remains largely unexplored.</div></div><div><h3>Objective</h3><div>This study aimed to evaluate the anti-inflammatory potential of different homeopathic potencies of <em>Glycyrrhiza glabra</em> against lipopolysaccharide (LPS)-induced inflammation in rats.</div></div><div><h3>Methods</h3><div>Male Wistar rats were divided into seven groups: normal control, LPS-induced inflammation control, dexamethasone-treated, <em>Glycyrrhiza glabra</em> homeopathic mother tincture (GHMT)-treated, and groups treated with <em>Glycyrrhiza glabra</em> homeopathic potency (G6CH, G30CH, G200CH). Anti-inflammatory effects of GHMT, G6CH, G30CH, and G200CH were evaluated against LPS-induced inflammation by measuring paw volume, serum pro-inflammatory cytokine levels [tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6)], levels of oxidative stress biomarkers (superoxide dismutase, glutathione, and catalase) in paw tissues, and histopathological changes in inflamed paw tissues.</div></div><div><h3>Results</h3><div>The results demonstrated a significant reduction in paw volume in GHMT and G200CH-treated groups (p&lt;0.0001) as compared to the inflammation control group. Additionally, the levels of serum TNF-α and IL-6 were significantly lowered (p&lt;0.0001), and oxidative stress biomarkers showed significant improvement (p&lt;0.0001) in GHMT and G200CH-treated groups. Histopathological examination further confirmed the reversal of inflammation-induced tissue changes by <em>G. glabra</em> homeopathic formulations, indicating its anti-inflammatory activity.</div></div><div><h3>Conclusion</h3><div>These findings provide scientific evidence supporting the anti-inflammatory potential of homeopathic formulations of <em>Glycyrrhiza glabra</em>, particularly GHMT and G200CH. The study suggests that these homeopathic potencies could serve as promising alternative anti-inflammatory agents, warranting further research to elucidate the underlying molecular mechanisms.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101267"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145517072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vivo and in silico toxicity studies of hydroalcoholic extract of Vetiveria zizanioides roots 香根草根水酒精提取物的体内和硅毒性研究
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 DOI: 10.1016/j.jaim.2025.101256
Pranali B. Yeram, Amisha Vora, Yogesh A. Kulkarni

Background

Vetiveria zizanioides (L.) is a traditional Indian medicinal plant belonging to the family Poaceae. Hydroalcoholic extract of Vetiveria zizanioides has been studied for its various pharmacological effects, but a systematic scientific study on its safety has not been done.

Objective

To study the toxic effects of single and repeated doses of hydroalcoholic extract of Vetiveria zizanioides root, and to establish the toxicity profile of hydroalcoholic extract using in silico toxicity prediction tools.

Methods

Acute and repeated dose toxicity studies were conducted following OECD guidelines 423 and 407, respectively. The acute toxicity study was carried out on female Sprague Dawley rats at 2000 and 5000 mg/kg doses, with effects monitored for 14 days. A repeated dose toxicity study was performed through daily dosing of the hydroalcoholic extract (ethanol: water, 1:1 v/v) of Vetiveria zizanioides extract for 28 days at doses of 250 mg/kg, 500 mg/kg, and 1000 mg/kg. At the end of the study, hematological parameters, biochemical parameters, kidney function, and histopathology were evaluated in all animals. Additionally, In silico toxicity prediction of the bioactive present in Vetiveria zizanioides root extract was performed using ProTox-II. Phytoconstituents of Vetiveria zizanioides roots were identified using GC-MS analysis.

Results

Single dose administration of Vetiveria zizanioides extract at 5000 mg/kg showed no toxicity or morbidity. Similarly, repeated doses of extract over 28 days did not significantly impact hematological and biochemical parameters. However, a significant increase in ALT (P < 0.05) was noted at the highest dose (1000 mg/kg) of the extract. Histopathological examinations of the liver at this dose revealed mild changes in hepatocytes compared to the control animals. The toxicity prediction revealed that all identified compounds of Vetiveria zizanioides hydroalcoholic extract were free from cytotoxicity and mutagenicity. More than 50 percent of the compounds were found to be class 5 (2000 < LD50 ≤ 5000). However, few compounds were found to be hepatotoxic at high doses.

Conclusion

Vetiveria zizanioides extract may generally be safe, but long-term use at 1000 mg/kg in rats could pose a concern for liver toxicity. The results of the study indicate that Vetiveria zizanioides is safe for use up to 500 mg/kg in 28-day repeated dose toxicity study.
香根草是一种传统的印度药用植物,属于草科。香根草水醇提取物的各种药理作用已被研究,但其安全性尚未进行系统的科学研究。目的研究香根水醇提取物单次和重复给药对小鼠的毒性作用,并建立水醇提取物的硅毒性预测模型。方法分别按照OECD指南423和407进行急性和重复剂量毒性研究。对雌性Sprague Dawley大鼠进行了2000和5000 mg/kg剂量的急性毒性研究,并监测了14天的影响。通过每天以250 mg/kg、500 mg/kg和1000 mg/kg的剂量给药香根草提取物的水醇提取物(乙醇:水,1:1 v/v),进行重复剂量毒性研究,持续28天。在研究结束时,对所有动物的血液学参数、生化参数、肾功能和组织病理学进行评估。此外,利用ProTox-II对香根草根提取物的生物活性进行了硅毒性预测。采用气相色谱-质谱法对香根草根的成分进行了鉴定。结果单次给药5000mg /kg香根草提取物无毒性,无并发症。同样,重复剂量的提取物超过28天没有显著影响血液学和生化参数。然而,在最高剂量(1000 mg/kg)时,ALT显著增加(P < 0.05)。该剂量下肝脏的组织病理学检查显示,与对照动物相比,肝细胞有轻微变化。毒性预测结果表明,香根草水醇提取物中所有化合物均不具有细胞毒性和致突变性。超过50%的化合物被发现是5类(2000 < LD50≤5000)。然而,很少有化合物被发现在高剂量下具有肝毒性。结论香根草提取物在一般情况下是安全的,但在大鼠体内长期以1000 mg/kg剂量使用可能引起肝毒性。本研究结果表明,在28天的重复给药毒性研究中,香根草剂量为500 mg/kg是安全的。
{"title":"In vivo and in silico toxicity studies of hydroalcoholic extract of Vetiveria zizanioides roots","authors":"Pranali B. Yeram,&nbsp;Amisha Vora,&nbsp;Yogesh A. Kulkarni","doi":"10.1016/j.jaim.2025.101256","DOIUrl":"10.1016/j.jaim.2025.101256","url":null,"abstract":"<div><h3>Background</h3><div><em>Vetiveria zizanioides</em> (L.) is a traditional Indian medicinal plant belonging to the family Poaceae. Hydroalcoholic extract of <em>Vetiveria zizanioides</em> has been studied for its various pharmacological effects, but a systematic scientific study on its safety has not been done.</div></div><div><h3>Objective</h3><div>To study the toxic effects of single and repeated doses of hydroalcoholic extract of <em>Vetiveria zizanioides</em> root, and to establish the toxicity profile of hydroalcoholic extract using <em>in silico</em> toxicity prediction tools.</div></div><div><h3>Methods</h3><div>Acute and repeated dose toxicity studies were conducted following OECD guidelines 423 and 407, respectively. The acute toxicity study was carried out on female Sprague Dawley rats at 2000 and 5000 mg/kg doses, with effects monitored for 14 days. A repeated dose toxicity study was performed through daily dosing of the hydroalcoholic extract (ethanol: water, 1:1 v/v) of <em>Vetiveria zizanioides</em> extract for 28 days at doses of 250 mg/kg, 500 mg/kg, and 1000 mg/kg. At the end of the study, hematological parameters, biochemical parameters, kidney function, and histopathology were evaluated in all animals. Additionally, <em>In silico</em> toxicity prediction of the bioactive present in <em>Vetiveria zizanioides</em> root extract was performed using ProTox-II. Phytoconstituents of <em>Vetiveria zizanioides</em> roots were identified using GC-MS analysis.</div></div><div><h3>Results</h3><div>Single dose administration of <em>Vetiveria zizanioides</em> extract at 5000 mg/kg showed no toxicity or morbidity. Similarly, repeated doses of extract over 28 days did not significantly impact hematological and biochemical parameters. However, a significant increase in ALT (P &lt; 0.05) was noted at the highest dose (1000 mg/kg) of the extract. Histopathological examinations of the liver at this dose revealed mild changes in hepatocytes compared to the control animals. The toxicity prediction revealed that all identified compounds of <em>Vetiveria zizanioides</em> hydroalcoholic extract were free from cytotoxicity and mutagenicity. More than 50 percent of the compounds were found to be class 5 (2000 &lt; LD50 ≤ 5000). However, few compounds were found to be hepatotoxic at high doses.</div></div><div><h3>Conclusion</h3><div><em>Vetiveria zizanioides</em> extract may generally be safe, but long-term use at 1000 mg/kg in rats could pose a concern for liver toxicity. The results of the study indicate that <em>Vetiveria zizanioides</em> is safe for use up to 500 mg/kg in 28-day repeated dose toxicity study.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101256"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145463170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the pharmacokinetic interactions between cisplatin and Triphala through in-vitro, in-vivo, and in-silico approaches – A pilot study to bridge modern medicine with Ayurveda 通过体外、体内和计算机方法探索顺铂和Triphala之间的药代动力学相互作用——一项连接现代医学与阿育吠陀医学的试点研究。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 DOI: 10.1016/j.jaim.2025.101253
T.K. Girija Kumari , Kamatchi Sundara Saravanan , Lakshmi M. Sundar , Gouri Nair , G.N.S. Hemasree , Ganesan Rajalekshmi Saraswathy

Background

Herbal drugs are often used alongside conventional cancer therapies to mitigate the adverse effects and enhance therapeutic efficacy. Triphala, a traditional herbal formulation used in Ayurveda, is known for its anticancer and CYP2E1 inhibitory properties. Cisplatin, although highly effective in cancer treatment, is known to cause significant hepatotoxicity and nephrotoxicity which are mediated by toxic metabolites formed through CYP2E1 metabolism.

Objective

The objective of this study is to explore the pharmacokinetic drug interactions between Triphala and cisplatin.

Methods

At the outset, the pharmacokinetic interactions between Triphala and cisplatin were confirmed by in-vitro experiments using HepG2 and 786-0 cell lines based on Reactive Oxygen Species (ROS) generation and cell viability assay, and in-vivo study using Sprague Dawley rats based on serum cisplatin concentration. Later, the literature derived phytoconstituents were subjected to in-silico studies to investigate their molecular interactions with the metabolizing enzyme CYP2E1.

Results

In-vitro studies revealed a reduction in ROS generation and enhanced cell viability, indicating that the metabolism of cisplatin is hindered by Triphala, which was attributed to its CYP2E1 inhibitory potential. In-vivo studies showed a marginal increase in cisplatin concentrations in rat serum that received the combination of Triphala and cisplatin, supporting the in-vitro findings. In-silico studies revealed that Triphala constituents, especially gallic acid and 3,5-dihydroxy-4-methoxybenzoic acid, stably bind and potentially inhibit CYP2E1 via key interactions with THR303.

Conclusion

The results suggest that Triphala may interact with cisplatin by inhibiting the CYP2E1 enzyme, potentially affecting the metabolism and toxicity of cisplatin. These findings highlight the need for further research to evaluate the clinical implications of using Triphala alongside cisplatin-based cancer therapies.
背景:草药通常与传统的癌症治疗一起使用,以减轻不良反应,提高治疗效果。Triphala是阿育吠陀中使用的一种传统草药配方,以抗癌和抑制CYP2E1而闻名。顺铂虽然在癌症治疗中非常有效,但已知会引起显著的肝毒性和肾毒性,这些毒性是通过CYP2E1代谢形成的毒性代谢物介导的。目的:探讨曲非拉与顺铂的药代动力学相互作用。方法:首先,通过HepG2和786-0细胞系体外实验(基于活性氧(ROS)生成和细胞活力测定)和Sprague Dawley大鼠体内实验(基于血清顺铂浓度)验证Triphala与顺铂的药代动力学相互作用。随后,对文献中衍生的植物成分进行了计算机研究,以研究它们与代谢酶CYP2E1的分子相互作用。结果:体外研究显示,ROS生成减少,细胞活力增强,表明Triphala阻碍顺铂的代谢,这归因于其CYP2E1抑制潜能。体内研究显示,接受Triphala和顺铂联合治疗的大鼠血清中顺铂浓度略有增加,支持体外研究结果。硅晶研究表明,Triphala成分,特别是没食子酸和3,5-二羟基-4-甲氧基苯甲酸,通过与THR303的关键相互作用稳定地结合并潜在地抑制CYP2E1。结论:黄芪多糖可能通过抑制CYP2E1酶与顺铂相互作用,影响顺铂的代谢和毒性。这些发现强调需要进一步的研究来评估Triphala与以顺铂为基础的癌症治疗联合使用的临床意义。
{"title":"Exploring the pharmacokinetic interactions between cisplatin and Triphala through in-vitro, in-vivo, and in-silico approaches – A pilot study to bridge modern medicine with Ayurveda","authors":"T.K. Girija Kumari ,&nbsp;Kamatchi Sundara Saravanan ,&nbsp;Lakshmi M. Sundar ,&nbsp;Gouri Nair ,&nbsp;G.N.S. Hemasree ,&nbsp;Ganesan Rajalekshmi Saraswathy","doi":"10.1016/j.jaim.2025.101253","DOIUrl":"10.1016/j.jaim.2025.101253","url":null,"abstract":"<div><h3>Background</h3><div>Herbal drugs are often used alongside conventional cancer therapies to mitigate the adverse effects and enhance therapeutic efficacy. Triphala, a traditional herbal formulation used in Ayurveda, is known for its anticancer and CYP2E1 inhibitory properties. Cisplatin, although highly effective in cancer treatment, is known to cause significant hepatotoxicity and nephrotoxicity which are mediated by toxic metabolites formed through CYP2E1 metabolism.</div></div><div><h3>Objective</h3><div>The objective of this study is to explore the pharmacokinetic drug interactions between Triphala and cisplatin.</div></div><div><h3>Methods</h3><div>At the outset, the pharmacokinetic interactions between Triphala and cisplatin were confirmed by <em>in-vitro</em> experiments using HepG2 and 786-0 cell lines based on Reactive Oxygen Species (ROS) generation and cell viability assay, and <em>in-vivo</em> study using Sprague Dawley rats based on serum cisplatin concentration. Later, the literature derived phytoconstituents were subjected to <em>in</em><em>-</em><em>silico</em> studies to investigate their molecular interactions with the metabolizing enzyme CYP2E1.</div></div><div><h3>Results</h3><div><em>In-vitro</em> studies revealed a reduction in ROS generation and enhanced cell viability, indicating that the metabolism of cisplatin is hindered by Triphala, which was attributed to its CYP2E1 inhibitory potential. <em>In-vivo</em> studies showed a marginal increase in cisplatin concentrations in rat serum that received the combination of Triphala and cisplatin, supporting the <em>in-vitro</em> findings. <em>In</em><em>-</em><em>silico</em> studies revealed that Triphala constituents, especially gallic acid and 3,5-dihydroxy-4-methoxybenzoic acid, stably bind and potentially inhibit CYP2E1 via key interactions with THR303.</div></div><div><h3>Conclusion</h3><div>The results suggest that Triphala may interact with cisplatin by inhibiting the CYP2E1 enzyme, potentially affecting the metabolism and toxicity of cisplatin. These findings highlight the need for further research to evaluate the clinical implications of using Triphala alongside cisplatin-based cancer therapies.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101253"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145512859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of yoga regimen on the lung capacity of defence personnel deployed at high altitude area 瑜伽养生对部署在高海拔地区的国防人员肺活量的影响。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 DOI: 10.1016/j.jaim.2025.101223
Lakhvinder Singh, Rithika Keshav, Mangesh Pandey, Natesh Babu

Background

High-altitude survival is difficult due to low oxygen levels. Good lung function and oxygen saturation are essential for optimum health. India's northern borders, characterized by mountainous terrain, remain vulnerable to infiltrators and enemies. Defence personnel assigned to these areas often face health challenges due to sudden shifts from low to high altitudes. Therefore, proper acclimatization is vital. Studies suggest yoga improves lung function and oxygen saturation, aiding adaptation.

Objective

This study explores whether the regular practice of yoga can help defence personnel stay prepared for high-altitude deployment by examining lung function, oxygen saturation, and heart rate.

Method

The present study, using a single-group pre-post design, evaluated the effectiveness of a yogic training program consisting of 50-min sessions administered over 20 consecutive days to twenty-two defence personnel deployed in a high-altitude area. The assessments for various Lung Function, Oxygen Saturation and Heart Rate were conducted before and after the intervention.

Results

The results demonstrated significant improvement in lung function and SPO2. Statistically significant improvements were observed in expiratory flow rate (p < 0.001), bhramari time (p < 0.001), breath-holding time (p < 0.001), oxygen saturation (p < 0.001), and heart rate (p = 0.033).

Conclusions

Yogic practices—especially postures with breath awareness, breathing techniques, and mindfulness—significantly enhance lung function, including breath-holding and oxygen saturation. Integrating yoga into defence personnel routines may boost tolerance to hypoxia and improve operational performance. Further research is needed to assess yoga's impact on physical and mental fitness in high-altitude conditions.
背景:由于低氧水平,高海拔生存是困难的。良好的肺功能和氧饱和度对最佳健康状况至关重要。印度的北部边界以多山地形为特征,仍然容易受到渗透者和敌人的攻击。被派往这些地区的国防人员由于从低海拔突然转为高海拔,往往面临健康挑战。因此,适当的适应是至关重要的。研究表明,瑜伽可以改善肺功能和氧饱和度,有助于适应。目的:本研究通过检测肺功能、血氧饱和度和心率,探讨常规瑜伽练习是否能帮助国防人员为高原部署做好准备。方法:本研究采用单组岗前设计,对部署在高海拔地区的22名国防人员进行了为期20天、每次50分钟的瑜伽训练计划的有效性评估。评估干预前后肺功能、血氧饱和度、心率等指标。结果:结果显示肺功能和SPO2有明显改善。结论:瑜伽练习——尤其是有呼吸意识、呼吸技巧和正念的姿势——显著增强肺功能,包括屏气和氧饱和度。将瑜伽融入国防人员的日常工作中可以提高对缺氧的耐受性,提高作战表现。需要进一步的研究来评估瑜伽对高海拔环境下身心健康的影响。
{"title":"Effect of yoga regimen on the lung capacity of defence personnel deployed at high altitude area","authors":"Lakhvinder Singh,&nbsp;Rithika Keshav,&nbsp;Mangesh Pandey,&nbsp;Natesh Babu","doi":"10.1016/j.jaim.2025.101223","DOIUrl":"10.1016/j.jaim.2025.101223","url":null,"abstract":"<div><h3>Background</h3><div>High-altitude survival is difficult due to low oxygen levels. Good lung function and oxygen saturation are essential for optimum health. India's northern borders, characterized by mountainous terrain, remain vulnerable to infiltrators and enemies. Defence personnel assigned to these areas often face health challenges due to sudden shifts from low to high altitudes. Therefore, proper acclimatization is vital. Studies suggest yoga improves lung function and oxygen saturation, aiding adaptation.</div></div><div><h3>Objective</h3><div>This study explores whether the regular practice of yoga can help defence personnel stay prepared for high-altitude deployment by examining lung function, oxygen saturation, and heart rate.</div></div><div><h3>Method</h3><div>The present study, using a single-group pre-post design, evaluated the effectiveness of a yogic training program consisting of 50-min sessions administered over 20 consecutive days to twenty-two defence personnel deployed in a high-altitude area. The assessments for various Lung Function, Oxygen Saturation and Heart Rate were conducted before and after the intervention.</div></div><div><h3>Results</h3><div>The results demonstrated significant improvement in lung function and SPO<sub>2</sub>. Statistically significant improvements were observed in expiratory flow rate (<em>p</em> &lt; 0.001), bhramari time (<em>p</em> &lt; 0.001), breath-holding time (<em>p</em> &lt; 0.001), oxygen saturation (<em>p</em> &lt; 0.001), and heart rate (<em>p</em> = 0.033).</div></div><div><h3>Conclusions</h3><div>Yogic practices—especially postures with breath awareness, breathing techniques, and mindfulness—significantly enhance lung function, including breath-holding and oxygen saturation. Integrating yoga into defence personnel routines may boost tolerance to hypoxia and improve operational performance. Further research is needed to assess yoga's impact on physical and mental fitness in high-altitude conditions.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101223"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145438162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In-vivo effects of IVT-15 - A traditional knowledge-inspired formulation for the management of rheumatoid arthritis IVT-15的体内效应-一种传统的知识启发制剂,用于类风湿关节炎的管理。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 DOI: 10.1016/j.jaim.2025.101216
Dnyaneshwar U. Bawankule , Amit Kaushik , Mridula Sahu , Dewasya P. Singh , Aashcharya U. Mishra , Vineet Babu , Princi Gupta , Ashutosh K. Shukla , Velusamy Sundaresan , Ritu Trivedi , Karuna Shanker , Debabrata Chanda , Anirban Pal , Mahendra P. Darokar , Narayan P. Yadav , Atul Gupta , Daya N. Mani , Suman P.S. Khanuja

Background

- Cyperus scariosus, Zingiber officinale, and Piper longum are known and used in Ayurveda to manage rheumatoid arthritis (RA). Due to their intrinsic properties, these plants fight diseases from different aspects. Combination of the three is suspected to provide all-around approach to manage RA and related disorders.

Objective

- The study aims to scientifically validate the efficacy of IVT-15 (combination of C. scariosus, Z. officinale, and P. longum) against RA and related disorders.

Materials & methods

IVT-15 was prepared by mixing aqueous extracts of the three plants in 1:1:1 ratio and analysed using high performance liquid chromatography (HPLC) for authenticating plant materials. IVT-15, a chemically defined formulation was further scientifically validated for safety and efficacy. Acute and subacute toxicity studies were performed on Swiss albino mice and efficacy was studied on standard animal models.

Results

Chemical profiling revealed high presence of 6-gingerol, α-cyperone, and piperine, and toxicity studies proved IVT-15 to be safe up to 2000 mg/kg body weight single dose acute oral toxicity study. IVT-15 revealed its in vivo anti-arthritic efficacy by reducing arthritis score and index significantly against collagen-induced arthritis. Reduction of tumor necrosis factor (TNF)-α, interleukin-1β (IL-1β), and interleukin-6 (IL-6) in lipopolysaccharide (LPS)-induced inflammation confirmed anti-inflammatory potential of IVT-15. Further in vivo testing indicated that IVT-15 has potential analgesic and immunomodulatory properties.

Conclusion

This study proves that IVT-15 can be used as alternative medicine for managing RA. Future clinical studies on IVT-15 will help in realizing its full healthcare benefits against arthritis.
背景:沙柏、生姜和长笛草在阿育吠陀医学中被用来治疗类风湿性关节炎(RA)。由于这些植物的内在特性,它们可以从不同的方面对抗疾病。三者的结合可能为RA及相关疾病的治疗提供全面的方法。目的:-本研究旨在科学验证IVT-15 (C. scariosus, Z. officinale, P. longgum)联合治疗RA及相关疾病的疗效。材料与方法:将三种植物的水提液按1:1:1的比例混合制备IVT-15,采用高效液相色谱(HPLC)进行鉴定。IVT-15是一种化学定义的制剂,其安全性和有效性得到了进一步的科学验证。对瑞士白化病小鼠进行了急性和亚急性毒性研究,并对标准动物模型进行了疗效研究。结果:化学分析显示6-姜辣素、α-环己酮和胡椒碱的含量很高,毒性研究证明IVT-15在2000 mg/kg体重的单剂量下是安全的。IVT-15对胶原性关节炎的体内抗关节炎作用表现为明显降低关节炎评分和指数。在脂多糖(LPS)诱导的炎症中,肿瘤坏死因子(TNF)-α、白细胞介素-1β (IL-1β)和白细胞介素-6 (IL-6)的降低证实了IVT-15的抗炎作用。进一步的体内试验表明,IVT-15具有潜在的镇痛和免疫调节特性。结论:本研究证明IVT-15可作为治疗RA的替代药物。未来对IVT-15的临床研究将有助于实现其对关节炎的全部医疗保健益处。
{"title":"In-vivo effects of IVT-15 - A traditional knowledge-inspired formulation for the management of rheumatoid arthritis","authors":"Dnyaneshwar U. Bawankule ,&nbsp;Amit Kaushik ,&nbsp;Mridula Sahu ,&nbsp;Dewasya P. Singh ,&nbsp;Aashcharya U. Mishra ,&nbsp;Vineet Babu ,&nbsp;Princi Gupta ,&nbsp;Ashutosh K. Shukla ,&nbsp;Velusamy Sundaresan ,&nbsp;Ritu Trivedi ,&nbsp;Karuna Shanker ,&nbsp;Debabrata Chanda ,&nbsp;Anirban Pal ,&nbsp;Mahendra P. Darokar ,&nbsp;Narayan P. Yadav ,&nbsp;Atul Gupta ,&nbsp;Daya N. Mani ,&nbsp;Suman P.S. Khanuja","doi":"10.1016/j.jaim.2025.101216","DOIUrl":"10.1016/j.jaim.2025.101216","url":null,"abstract":"<div><h3>Background</h3><div><u>-</u> <em>Cyperus scariosus</em>, <em>Zingiber officinale</em>, and <em>Piper longum</em> are known and used in <em>Ayurveda</em> to manage rheumatoid arthritis (RA). Due to their intrinsic properties, these plants fight diseases from different aspects. Combination of the three is suspected to provide all-around approach to manage RA and related disorders.</div></div><div><h3>Objective</h3><div><u>-</u> The study aims to scientifically validate the efficacy of IVT-15 (combination of <em>C. scariosus</em>, <em>Z. officinale</em>, and <em>P. longum</em>) against RA and related disorders.</div></div><div><h3>Materials &amp; methods</h3><div>IVT-15 was prepared by mixing aqueous extracts of the three plants in 1:1:1 ratio and analysed using high performance liquid chromatography (HPLC) for authenticating plant materials. IVT-15, a chemically defined formulation was further scientifically validated for safety and efficacy. Acute and subacute toxicity studies were performed on Swiss albino mice and efficacy was studied on standard animal models.</div></div><div><h3>Results</h3><div>Chemical profiling revealed high presence of 6-gingerol, α-cyperone, and piperine, and toxicity studies proved IVT-15 to be safe up to 2000 mg/kg body weight single dose acute oral toxicity study. IVT-15 revealed its <em>in</em> <em>vivo</em> anti-arthritic efficacy by reducing arthritis score and index significantly against collagen-induced arthritis. Reduction of tumor necrosis factor (TNF)-α, interleukin-1β (IL-1β), and interleukin-6 (IL-6) in lipopolysaccharide (LPS)-induced inflammation confirmed anti-inflammatory potential of IVT-15. Further in vivo testing indicated that IVT-15 has potential analgesic and immunomodulatory properties.</div></div><div><h3>Conclusion</h3><div>This study proves that IVT-15 can be used as alternative medicine for managing RA. Future clinical studies on IVT-15 will help in realizing its full healthcare benefits against arthritis.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101216"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145400767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breaking silos in healthcare: A futuristic vision for Viksit Bharat 打破医疗保健领域的孤岛:维克西特·巴拉特的未来愿景。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 DOI: 10.1016/j.jaim.2025.101288
Bhushan Patwardhan , Gururaj Mutalik , Girish Tillu
{"title":"Breaking silos in healthcare: A futuristic vision for Viksit Bharat","authors":"Bhushan Patwardhan ,&nbsp;Gururaj Mutalik ,&nbsp;Girish Tillu","doi":"10.1016/j.jaim.2025.101288","DOIUrl":"10.1016/j.jaim.2025.101288","url":null,"abstract":"","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101288"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145400732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterization and effect of Naga Bhasma on hypoglycemic, antihyperglycemic, and antidiabetic activities in Charles Foster diabetic rats 那迦树对查尔斯·福斯特糖尿病大鼠降血糖、降高血糖和降糖尿病活性的表征和影响。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 DOI: 10.1016/j.jaim.2025.101226
Pravin Tate , B.J. Patgiri , P.K. Prajapati , B. Ravishankar

Background

Diabetes, typically characterized by hyperglycaemia, is a leading cause of morbidity and mortality. Over 800 million adults were estimated to have diabetes in 2022. Ayurveda texts emphasized on the antidiabetic potential of Naga Bhasma (NB) (a lead based formulation). Naga Bhasma is used in many classical antidiabetic formulations such as Vasantkusumakara Rasa.

Objectives

Present study was planned to evaluate hypoglycemic, antihyperglycemic, and antidiabetic activities of Naga Bhasma in euglycemic, sucrose loaded hyperglycemic and streptozotocin induced diabetic Charles Foster albino rats.

Material and methods

NB was prepared following classical texts of Ayurveda. Charles Foster albino rats were used for antidiabetic study. The study was divided into: hypoglycaemic, antihyperglycemic, and antidiabetic parts. Hypoglycaemic study was aimed to assess glucose lowering activity in normal rats. Antihyperglycemic study was carried out to assess the effect of test drug on blood sugar elevation observed after administration of sucrose (40 g/kg orally). For antidiabetic study, streptozotocin was injected intraperitoneally (40 mg/kg) to induce diabetes. Vehicles were administered on 3rd day of streptozotocin injection, after confirmation of diabetes. Blood sugar was checked before and on 5th day after vehicle administration. The data was analysed by unpaired ‘t’ test.

Results

Hypoglycaemic study did not show any significant effect on blood glucose in NB group. In Antihyperglycemic study, NB administered group showed only statistically non-significant increase in blood sugar level at 4th and 8th hour indicating presence of anti-hyperglycemic activity. In antidiabetic study, in control group, a statistically significant (48.90 %) elevation of blood sugar level was observed while in NB administered group highly significant (69.58 %) decrease was observed in comparison to initial values.

Conclusion

The study shows that NB has moderate anti-hyperglycaemic and good anti-diabetic activity; and it does not lower the blood glucose below the normal levels.
背景:糖尿病,以高血糖为典型特征,是发病率和死亡率的主要原因。到2022年,估计有超过8亿成年人患有糖尿病。阿育吠陀文献强调了那迦巴什玛(NB)(一种铅基制剂)的抗糖尿病潜力。在许多经典的抗糖尿病配方中,如Vasantkusumakara Rasa中使用了那伽巴什玛。目的:本研究拟评价长毛藤对高血糖、蔗糖负荷高血糖和链脲佐菌素诱导的糖尿病大鼠的降糖、降糖和降糖作用。材料和方法:NB是根据阿育吠陀经典文献制备的。采用Charles Foster白化大鼠进行抗糖尿病研究。该研究分为:降糖、降糖和降糖三个部分。降糖研究旨在评估正常大鼠的降糖活性。采用降糖研究评价试验药物对口服蔗糖(40 g/kg)后血糖升高的影响。在降糖研究中,腹腔注射链脲佐菌素(40 mg/kg)诱导糖尿病。在确认糖尿病后,于第3天给药链脲佐菌素。分别于给药前和给药后第5天检测血糖。数据采用非配对t检验进行分析。结果:降糖研究未发现NB组对血糖有明显影响。在降糖研究中,NB给药组仅在第4和第8小时血糖水平无统计学意义的升高,表明存在降糖活性。在降糖研究中,对照组血糖水平升高有统计学意义(48.90%),而给药组血糖水平较初始值显著降低(69.58%)。结论:研究表明,NB具有中等降糖和良好的抗糖尿病活性;而且它不会将血糖降低到正常水平以下。
{"title":"Characterization and effect of Naga Bhasma on hypoglycemic, antihyperglycemic, and antidiabetic activities in Charles Foster diabetic rats","authors":"Pravin Tate ,&nbsp;B.J. Patgiri ,&nbsp;P.K. Prajapati ,&nbsp;B. Ravishankar","doi":"10.1016/j.jaim.2025.101226","DOIUrl":"10.1016/j.jaim.2025.101226","url":null,"abstract":"<div><h3>Background</h3><div>Diabetes, typically characterized by hyperglycaemia, is a leading cause of morbidity and mortality. Over 800 million adults were estimated to have diabetes in 2022. <em>Ayurveda</em> texts emphasized on the antidiabetic potential of <em>Naga Bhasma</em> (NB) (a lead based formulation). <em>Naga Bhasma</em> is used in many classical antidiabetic formulations such as <em>Vasantkusumakara Rasa</em>.</div></div><div><h3>Objectives</h3><div>Present study was planned to evaluate hypoglycemic, antihyperglycemic, and antidiabetic activities of <em>Naga Bhasma</em> in euglycemic, sucrose loaded hyperglycemic and streptozotocin induced diabetic Charles Foster albino rats.</div></div><div><h3>Material and methods</h3><div>NB was prepared following classical texts of Ayurveda. Charles Foster albino rats were used for antidiabetic study. The study was divided into: hypoglycaemic, antihyperglycemic, and antidiabetic parts. Hypoglycaemic study was aimed to assess glucose lowering activity in normal rats. Antihyperglycemic study was carried out to assess the effect of test drug on blood sugar elevation observed after administration of sucrose (40 g/kg orally). For antidiabetic study, streptozotocin was injected intraperitoneally (40 mg/kg) to induce diabetes. Vehicles were administered on 3rd day of streptozotocin injection, after confirmation of diabetes. Blood sugar was checked before and on 5th day after vehicle administration. The data was analysed by unpaired ‘t’ test.</div></div><div><h3>Results</h3><div>Hypoglycaemic study did not show any significant effect on blood glucose in NB group. In Antihyperglycemic study, NB administered group showed only statistically non-significant increase in blood sugar level at 4th and 8th hour indicating presence of anti-hyperglycemic activity. In antidiabetic study, in control group, a statistically significant (48.90 %) elevation of blood sugar level was observed while in NB administered group highly significant (69.58 %) decrease was observed in comparison to initial values.</div></div><div><h3>Conclusion</h3><div>The study shows that NB has moderate anti-hyperglycaemic and good anti-diabetic activity; and it does not lower the blood glucose below the normal levels.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101226"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145458740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Ayurveda and Integrative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1